Too Many Resubmissions Have Been Received

Home  »   Funding   »  Funding Opportunities (RFAs, PAs) & Notices   »  Frequently Asked Questions - Resubmissions of NIH Research Grant Applications

Oftentimes Asked Questions

Resubmissions of NIH Applications

Final Revised: March 7, 2022

  A. Resubmission Policy Basics

1. What is the current policy on resubmissions?

   Only a single resubmission (A1) of an original awarding (A0) will be accepted.

   Following an unsuccessful resubmission (A1) application, applicants may submit the same thought every bit a new (A0) awarding for the next appropriate new application due appointment (meet Non-OD-eighteen-197 for exceptions).

   Resubmissions (A1) must exist submitted within 37 months of the new (A0) application (encounter NOT-OD-10-140 and NOT-OD-12-128).

   For more details on the Resubmission Policy, visit the Resubmissions webpage and meet NOT-OD-eighteen-197.

2. What types of grant programs does the resubmission policy apply to?

   NIH's resubmission policy applies to applications submitted to all grant and cooperative understanding funding opportunities that let resubmissions, including all fellowship, preparation, and career development awards.

4. Are resubmissions of revisions allowed?

   Mostly. The funding opportunity announcement will indicate whether resubmissions of revisions are allowed.

5. Must I expect for my summary statement before submitting my idea again?

   In one case your application has been reviewed, yous must wait for the summary statement to be issued before you resubmit that application or submit whatever other application with substantial scientific overlap.

6. I just received my score and it is non very encouraging. The next submission date for the FOA is simply a few days away; may I withdraw this awarding before the summary statement is released and submit some other application right away?

   Even though you tin can submit your work once again, NIH expects applicants to strengthen and improve their applications with each submission—using a combination of your ain enquiry progress, updates from the literature, and feedback provided in the summary statement.

7. May I submit a new application post-obit an unsuccessful new awarding?

   Yep.  The policy does not require a resubmission (A1) before submission of a new (A0) application.

8. Is there a limit to the number of times an awarding may be submitted as new?

   No. The number of such cycles is not limited, but NIH encourages applicants to update their applications to reflect the status of the field over the acting period and to incorporate new preliminary information, literature citations, letters of reference, etc. as fourth dimension passes.

9. Is there a limit to the number of times an application may exist submitted as a renewal application?

   If the award can be renewed, you may submit i renewal application followed by i resubmission of that renewal application to an appropriate funding opportunity declaration.

   • If the renewal application is not funded, your options are to submit an A1 resubmission awarding or to submit a new type 1 application.
   • If the resubmission application is non funded, your side by side option is to submit a new type one application.  Run across Non-OD-15-059 for data about the content differences between new, renewal, and resubmission applications.

10. What application due date should I use when submitting a "new" that NIH has reviewed previously?

    All applications submitted as new must target due dates designated for new applications, regardless of whether the previous submission was a competing renewal, a resubmission, or a new application.

12. May I modify funding opportunity announcements between submission of a new or renewal (A0) application and the corresponding resubmission (A1) application?

    Generally, yeah, but in that location are some specific limitations:

    • You cannot submit the resubmission (A1) awarding to a funding opportunity annunciation that does not take resubmissions
    • You cannot submit the resubmission (A1) application to an RFA if the new or renewal (A0) application was submitted to a PA, PAR, or PAS
    • You cannot submit the resubmission (A1) application to a PA, PAR, or PAS if the new or renewal (A0) awarding was submitted to a RFA
    • You lot cannot submit a resubmission (A1) application to an RFA that merely accepts resubmissions from specified funding opportunity announcements unless y'all used one of those specified FOAs to submit the new or renewal (A0) application

    All requirements of the funding opportunity announcement used for the resubmission (A1) application must be followed.

13. I originally applied to the Parent R01, which has since been expired. When I resubmit to the new Parent R01 – Clinical Trial Required, may I submit an A1 (resubmission) or must the application be submitted as new (A0 application)?

    An application submitted equally new to i Program Annunciation (like the Parent R01) may exist resubmitted as an A1 (resubmission) to any other Plan Announcement, so long as that programme announcement accepts resubmissions and information technology is submitted within 37 months of the A0 (original, new) submission.

Back to Top

  B. Understanding a New Application vs a Resubmission Application

1. What distinguishes a new application from a resubmission awarding?

   A resubmission application must comprise an Introduction, which addresses the comments from the previous review; a new application makes no reference to a previous submission.

2. Can I submit a resubmission application if the funding opportunity announcement says resubmissions are immune, or tin can I submit a new application instead?

   An A1 application is the simply mode that you may specifically address the critiques of the previous review.  A new awarding may not take an introduction responding to the previous critiques, and can only exist submitted after the summary statement is received, unless the funding opportunity declaration says otherwise.  All applicants should submit applications that reverberate the current status of the field, new preliminary data, or new plans in response to new findings or strategies.

3. Is there a benefit to submitting a resubmission rather than a new awarding?

   A resubmission allows you to provide a one folio introduction to tell reviewers direct how you have addressed their critiques. Alternatively, the introduction allows y'all to explain why you did non address them.

4. My awarding was non discussed. Should I develop a new awarding or effort to address the reviewers' comments in a Resubmission application?

   This event should be considered on a case-past-example basis. Read the summary statement carefully and notation weaknesses that y'all could accost in a reasonable length of fourth dimension. Discuss the critiques with your collaborators, colleagues, and/or senior researchers/mentors to become their suggestions. The PO besides can discuss your options going forward. It is possible for an awarding that carefully addresses the reviewers' comments to become from being "not-discussed" to receiving outstanding scores upon resubmission.

5. Am I immune to submit the same application as a new and a resubmission awarding in the same Council circular?

   Generally, no. NIH volition non allow duplicate or highly overlapping applications to be under review at the same time. This includes: ane) a new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application; and ii) a resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application. (NOT-OD-eighteen-197)

6. My resubmission application was non funded. May I now submit it every bit a new application?

   Yes. Investigators should accept into account the scores of the previous application, the reviewer comments, and any communication from NIH programme staff when deciding whether to submit the application every bit new. Should you decide to submit the application as new, take reward of the comments from reviewers to reshape your application, but remember, you should non directly reference the previous review in the new application. If the previous awarding was a renewal resubmission, the new application should not include a Progress Written report or a Progress Written report Publication List. (Note special rules utilize for submitting after an unsuccessful Phase Ii SBIR/STTR application.) Piece of work from the prior funding period should be presented as preliminary information and/or rationale for the proposed enquiry. Publications from the prior work may be cited in the reference list, as applicative, and/or listed in the biosketches of the investigators.

7. My new application follows an unsuccessful application on the same topic and ideas. I know that I may not include an Introduction. May I include information elsewhere in the application to address the previous review?

   No.  A new application must be prepared equally a new application. You may not include previous scores, comments of the previous reviewers, your responses to those comments, or place marks in the text of the research strategy or whatsoever other section of the application to point changes from a previous submission. Remind collaborators providing letters of support not to refer to previous submissions or reviews, and for applications requiring reference messages, remind your referees that these letters should not include any references to a previous awarding or review.

8. Will my new awarding be reviewed if it contains reference to a previous review outcome?

   No. Your awarding will be withdrawn from the review process if y'all include anywhere in the your awarding the kind of information that would be constitute in a previous summary statement (score, critique criterion scores, reviewers comments), information that would be advisable for an Introduction (response to the previous review and information nigh how the application was changed), or marks in the text of the application to show how it has changed since the terminal submission.

9. Since my new awarding is substantially a "resubmission" of an earlier application, may I submit it for the resubmission due date listed in the FOA?

   No. If you submit your application every bit a new A0 application, it must exist submitted for the new application due date, regardless of the by review history for this project. If you submit the new awarding on the resubmission due date, information technology will be withdrawn for beingness late.

10. My resubmission of a competing renewal awarding (Blazon two A1) was non funded. May I submit a new renewal (Type 2 A0)?

    No. Only a single resubmission of a competing new, revision, or renewal application (A0) will be accepted. Afterward a resubmission of a competing renewal (Type 2) application that is not funded, a subsequent new renewal (Type 2 A0) application may non be submitted. The next application submitted on this topic should exist submitted equally a new application (Type ane A0) on an appropriate due appointment for new applications (see Not-OD-18-197 for exceptions).

11. Volition a Type 1 A0 application following an unfunded competing renewal awarding still be considered a renewal application if I submit it equally new?

    No. As a new Type 1, the application would be due on the new application due date, not the renewal application due date. The awarding must not comprise a Progress Report, Progress Report Publication List or response to previous critiques in an Introduction or elsewhere in the application.

12. How can I nowadays data to show progress in my work if I cannot include a Progress Report in my application?

    You may present the data generated during your grant in the preliminary information section of your new application. Y'all may include publications in your biosketch and cite them as support for your enquiry plans.

13. I had an institutional training (or enquiry educational activity or career development) grant that was not renewed, and I now want to submit a new awarding for a similar program. How tin can I describe the experience with the previous program and how it influenced the proposed program?

    For an institutional training grant (T) or career development award (K) application, you can utilise the Background section to describe a previous programme and how it impacted the proposed program. For a enquiry education (R25) grant application, experience with a previous programme and its influence on the current application could be described in the Institutional Surround or Institutional Setting section. Yet, information regarding a previously funded program must not exist presented as a progress report or include elements of a progress study for the previous grant.

14. Will my new A0 application be reviewed if it contains a Progress Report or Progress Report Publication List?

    No. Those elements are not immune for a new application. New applications containing a Progress Report or Progress Report Publication List will be withdrawn before review.

15. Afterward an unfunded renewal application, I am submitting a new application that is actually a renewal of my project. May I submit it on the due date for renewal applications listed in the FOA?

    No. It is a new application and it must be submitted on the due date for new applications listed in the FOA. If it is submitted on the due date for renewal applications, it will be withdrawn for being belatedly.

16. If my resubmission (A1) has non yet been reviewed, may I withdraw this application and replace information technology with another resubmission?

    You may withdraw an A1 awarding before the appointment of review and submit another A1 for a later, appropriate due date. Note that NIH volition not accept a resubmission awarding that is submitted afterwards than 37 months after the due date of the initial (A0) awarding (see NOT-OD-x-140).

17. If my application has been reviewed, and the score released, may I submit an overlapping application, or withdraw the awarding and replace it with another one?

    No. Once your application has been reviewed, you must wait for the summary argument to be issued before submitting an awarding.

18. My investigator-initiated awarding was not funded. May I submit this application in response to an appropriate Request for Applications (RFA)?

    Yes. In most cases a previously unfunded investigator-initiated application that is submitted in response to an RFA is to be prepared as a new application. See NOT-OD-09-100.

19. If an application submitted in response to an RFA is not successful, is it considered new if I submit to a different funding opportunity?

    If the awarding is not successful through the RFA and is later on submitted to a different RFA or to a program announcement (such every bit the standard "parent" announcement), then it is considered a new application. If your application was submitted previously to a PA and y'all want to now submit it to an RFA, it is considered a new application. If you lot submit a new application to a PA and and then submit to an RFA, y'all tin subsequently resubmit to the PA as an A1. For more data on submission following an RFA review, encounter policy notice NOT-OD-09-100.

20. Are all submissions to RFAs new applications?

    For about RFAs that have a single receipt appointment, all applications will exist considered new. Some RFAs have multiple receipt dates and permit resubmission applications to the same RFA (designated with the grant number suffix "A1"). The text of each RFA should clearly state which types of applications are allowed (new, resubmission, renewal, revision). This can exist a complicated effect, and information technology is best to contact the plan official listed in the RFA.

21. Can I submit the same application to two different FOAs simultaneously?

    In almost cases, two or more applications that have scientific overlap in the experiments proposed are not allowed in peer review at the same time, even if 1 is to an RFA and the other(s) to a PA/PAR/PAS. There are exceptions to this rule. NIH allows subprojects of Program Project Grant applications to exist submitted every bit enquiry applications (R01, R03, R15, R21, etc.) in the same cycle. In well-nigh cases, a second application for the same project should not be submitted until afterwards the summary argument for the original submission has been released. Come across more information on overlapping applications.

22. Must I change an application that was already reviewed in order to submit it as new?

    Although NIH volition non assess the similarity of the science in the new (A0) application to any previous submission when accepting it for review, we encourage investigators to take into business relationship critiques from the previous review and communication from programme staff. Remember, duplicate or highly overlapping applications are non immune in review at the aforementioned time. Retrieve also that the NIH volition not take an A0 or A1 application if an appeal of initial peer review is awaiting on a substantially overlapping application.

Back to Superlative

  C. Preparing Your Application

1. When should I resubmit?

   Yous should consider the resubmission application when you tin address the weaknesses described in the summary statement. Often, additional preliminary data are needed to accost the criticisms. Therefore, you may demand to skip a due date or 2 and plan on including the results from boosted experiments. Notation that the standard due dates for resubmission applications are often afterward than those for new applications.  An application can exist resubmitted upwardly to 37 months after the original application's due date; later that, information technology must be submitted as a new application and non refer to the previous review. Notwithstanding, every bit the fourth dimension increases between the original application and the resubmission, reviewers may await more preliminary data, equally bear witness that the investigator is productive and committed to the project. Alternatively, you may discuss with your Program Officeholder the possibility of submitting a new application rather than a Resubmission awarding.

2. Do I need to respond to all of the reviewers' comments, or can I disregard comments that seem to me to exist unjustified?

   The introduction of your resubmission awarding should address all of the weaknesses described in the summary statement.  If yous disagree with a reviewer's argument, explain why, and provide boosted information.  Avoid responses that could be seen equally belligerent.  Inquire a colleague to read the reviewers' critiques and your responses prior to resubmission, to confirm that you have addressed the critique in a way that is informative and not-confrontational.

3. If my application is not funded, may I apply the same awarding form for the subsequent resubmission or new application?

   Possibly. If y'all are applying to a new funding opportunity annunciation (FOA), you must use the class associated with that FOA. When submitting to the same FOA as the previous application, yous must cheque the funding opportunity to make sure that no form updates accept happened since your previous submission.  If a more recent grade version is bachelor, you will need to transfer your information to that form. See Do I Have The Right Electronic Forms For My Application?

   
   

4. How do I distinguish the awarding as being a new application or a resubmission application on the awarding course?

   Box 8 of the SF 424 (R&R) encompass allows y'all to select the awarding blazon every bit either new or resubmission.

5. I am submitting a new application in the same topic area of science equally my unfunded resubmission application. Should I address my changes or the fact that this is a new application in a cover letter?

   You lot should not refer to the previous submissions in the cover letter of the alphabet to the new application, every bit it volition be given a new number and volition non be compared to the previous submissions when accepting it for review.

6. What is the page limit for the introduction to a Resubmission application and how do I indicate changes?

   Generally, the introduction is limited to 1 page unless otherwise specified in the FOA or Table of Folio Limits. For example, an exception is made for R25, Ts, Ds and some K applications, to let a iii folio introduction to the resubmission application.

   Identifying individual changes in the text of the specific aims, research strategy and other application attachments is no longer required (NOT-OD-15-030). It is sufficient to outline the changes fabricated to the Resubmission awarding in the Introduction zipper. The Introduction must include a summary of substantial additions, deletions, and changes to the application. Information technology must as well include a response to weaknesses raised in the Summary Statement.

7. Tin a Resubmission application take a different title than the original submission?

   Yes, your resubmission application can have a unlike title than your original application. However, if in that location is a significant change in the content and scope of the proposed research, it may be all-time to develop a new application.  Consult with your plan official for further guidance.

8. Can an boosted PD/PI be added or removed before submitting a resubmission application?

   A PD/PI can be added to or removed from the resubmission awarding. It is best to explicate these changes in the introduction of your application. A change of PD/PI also needs to be noted via a checkbox in the application.

9. Do I need to modify the title when I submit the awarding again as new?

   Non unless y'all desire to. Nosotros are updating the application guide to reverberate this policy change.

10. How practice I convey the changes I've fabricated in a resubmission application? (03/07/2022)

    Respond equally thoroughly as possible to all of the reviewers' comments in the "Introduction" attachment establish on the PHS 398 Research Program or equivalent form (i.eastward., PHS 398 Training Program Program, PHS Fellowship Supplemental Form, or PHS 398 Career Development Award Supplemental Form).

    The Introduction must include a summary of the substantial additions, deletions, and changes to the application, every bit well as, a response to the major weaknesses raised in the Summary Statement.

    Do not mark up changes within other application attachments (e.g., do not highlight, color, assuming or italicize changes in Research Strategy).

Dorsum to Meridian

  D. Time Limits for Resubmission Applications

1. When tin can an application no longer exist resubmitted?

   Resubmission applications may be submitted for an appropriate due date up to 37 months after the awarding due date of the initial application. Any application on the aforementioned topic that you lot submit more than than 37 months from the initial receipt date is considered a new awarding; it should not refer to the previous review(s) and must be submitted on the appropriate due engagement for new applications. (See related policy find.)

2. What happens to the time limit for resubmission applications if I choose to submit equally new instead of every bit a resubmission?

   The 37 month time limit for resubmissions starts with each application that is submitted every bit new.

3. Why does the NIH set a fourth dimension limit for resubmission applications?

   Because of the stride of scientific discovery, NIH limits the timeframe in which applicants can answer directly to feedback from peer review.

Dorsum to Top

  E. Implications of Various Changes to Your Application

1. Can an additional PD/PI exist added or removed before submitting a Resubmission application?

   A PD/PI tin be added to or removed from the resubmission application. Information technology is best to explain these changes in the introduction of your awarding. A change of PD/PI also needs to be noted via a checkbox in the awarding.

2. My R01 application was reviewed and was not funded. May I submit the awarding using a different activity code, for example, as an R21 (Exploratory/Developmental Research) grant?

   Yes, but you lot must wait until the summary statement for the previous submission is released and you need to look carefully at the requirements of the new activity lawmaking. Specifics for this activity are available at: NIH Exploratory/Developmental Research Grant Award. Annotation that not all ICs participate in this action. If the R01 application is inverse to focus on a subset of aims and submitted as an R21, those aims may not be included in a separate R01 submission. Come across Types of Grant Programs to learn about requirements for other activity codes. For more on the submission of applications with a changed activity code, visit NOT-OD-09-100.

3. Simply part of my application was funded: a) the telescopic of my work was reduced; and/or b) the length of time for my award was cut. May I submit a new grant awarding for the unfunded aims?

   Possibly. You can submit a new application that incorporates the deleted aims if at that place has been a renegotiation of the scope (specific aims) of the research grant application and you accept documentation from the funding IC to support the modify. Consult the program manager assigned to the application. This private is the programme contact shown in the upper left paw corner of your summary argument.

Dorsum to Top

  F. Review Issues

1. How are resubmission applications reviewed?

   Reviewers are instructed to evaluate the resubmission application as presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project. For resubmitted renewals, the commission will too consider the progress made in the final funding period.

2. May I asking that my Resubmission awarding exist reviewed by a different study section or take main assignment to a unlike NIH IC than my original application?

   Resubmission applications usually are assigned to the same study section and Institue/Center (IC) as the original application only you can request a change using the Consignment Request Form with the resubmission application following the instructions in the SF424 (R&R) Application Guide.  It is a skilful idea to consult with your Program Officeholder (PO) and/or Scientific Review Officer (SRO) to discuss whether a modify would be appropriate.

   The Division of Receipt and Referral (DRR) at the Eye for Scientific Review (CSR) is responsible for assigning applications to ICs and in some cases to Scientific Review Groups (SRGs). DRR normally accommodates requests if appropriately justified and requested well before the review meeting engagement, merely reserves the right to make the final conclusion. ICs websites describe mission involvement which can help applicants match topics of inquiry to the appropriate funding component. The CSR website provides data regarding the focus of expertise of each of the CSR standing study sections.

   Y'all may directly referral questions to the CSR Referral Office (CSRDRR@mail service.nih.gov or 301-435-0715).

3. What should I exercise if I practise non concur with my review group consignment or IC assignment?

   Contact the NIH scientific review officer assigned to your application to talk over the review consignment. While the SRO tin can look into the concern and describe the panel's expertise, in CSR the Integrated Review Group Main and in IC's the Review Branch Master has the authorisation to make assignment changes and should go involved when it is clear that a change is desired by the bidder.

   Contact the Partition of Receipt and Referral in the Center of Scientific Review to discuss the IC consignment (CSRDRR@mail.nih.gov  or 301 435-0715).

4. Are reviewers allowed to consider previous submissions when reviewing applications submitted as new?

   No. The scientific review officeholder will remind reviewers that they must only consider the information included in the new application.

5. Tin can I resubmit or submit my awarding equally new while my application is nether entreatment of the initial peer review?

   No.  The appeal must be resolved in order for you to submit that application again.

Back to Superlative

  G. Guidance for Reviewers

1. I take discovered a reference to a previous review in an application. Based on the policy for new (Blazon 1) A0 submissions, what should I do?

   Contact the SRO immediately. The application may need to be withdrawn from the review procedure.

2. In my critique of a Type 1 A0 awarding, may I refer to a previous critique or review of mine from a previous version of this application?

   No. Each new (Blazon 1) A0 awarding must be considered as a new submission and reviewers must consider simply the information included in the current application regardless of any prior submissions.

3. In my critique of a Blazon 1 A0 application, may I make whatsoever comments regarding a previous submission?

   No. Regardless of the nature of the comments, negative or positive, no reference to a prior submission of a new (Type 1) A0 is permitted in the written critique or during give-and-take of the application. In addition, reviewers should not refer to previous reviews or discussions in their written critiques or during discussion at a review meeting.

4. May I reuse my critique from a previous review for a Type 1 A0 awarding?

   No. This should not exist done. Reviewers are instructed by the SRO to regard as confidential all review-related materials and to securely dispose of all such materials in a timely style following the review meeting (published papers by the applicants are exempt). Storing prior critiques for potential hereafter utilize is non appropriate.

5. Although this is designated a new (Type i) A0 awarding, I accept reviewed this aforementioned awarding before, and the bidder has fabricated few or no changes. Why should I spend writing a complete new critique when most of the comments volition be the same and I could just slightly modify a previous critique?

   This is considered a new application, and any potential changes made by the applicant may not be readily credible. You should treat the application equally fairly as you would an application yous accept never seen before and be willing to consider the possibility that the applicant fabricated changes as s/he saw fit. If there are like strengths and weaknesses that impact the overall touch score, information technology is appropriate to recapitulate these points in the critique. Withal, it is inappropriate for reviewers to "copy and paste" previous critiques, which in any event you should no longer have available.

6. In reviewing a Blazon 1 A0 application that I have seen before, may I give a worse score than the application merits in order to discourage the applicant from submitting the same application again?

   No. The review of whatever new (Blazon 1) A0 awarding must be carried out in an unbiasedmanner without regard to whatsoever prior submission(s) of the same or similar application. The score should adequately reverberate the merit of the application at the fourth dimension it is submitted; this score may exist better or worse than a prior awarding—but scores should not be used to senda punitive message

7. May I propose Not Recommended for Further Consideration (NRFC) for an awarding that has been seen too many times?

   No. An application should be reviewed and rated on its merits, irrespective of the number of submissions of the same or similar awarding. NRFC is appropriate for applications that lack significant and substantial merit or present serious ethical issues in the protection of human subjects from research risks, utilise of vertebrate animals, biohazards and/or select agents. NRFC should not exist used punitively or to express badgerer at seeing an application as well many times. A proposal to NRFC requires a full discussion of the application by the review grouping, followed by a motility and a formal vote (with the number of members who vote for and against the motility—or abstain, recorded in the Summary Statement). Should reviewers wish to consider for NRFC an application that would otherwise fall in the ND range, the awarding must exist "rescued" during the streamlining procedure and will exist subsequently brought up for full give-and-take

8. There is an "Additional Comments to Applicant" section on the critique template. How can this be used to address issues and concerns related to previous submissions of applications designated Type one A0?

   The "Boosted Comments to Applicant" box was developed for reviewers to provide additional data or communication to the applicant (see http://grants.nih.gov/grants/peer/guidelines_general/Additional_Comments.pdf). The box may exist used to propose the applicant against submitting an application again unless there are significant changes in the application (you may specify where you think changes are well-nigh needed). Annotation, nonetheless, that these comments are not binding, practice not represent a consensus of the review panel and should not be considered in scoring the awarding. For new (Type i) A0 applications, the comments in this section, as with any part of your critique, must pertain to the current submission only and must not reference by submissions or reviews (if any).

Glossary:

A0: First submission
A1: First resubmission
A2: 2nd resubmission (not permitted after January 25, 2010, every bit described in NOT-OD-x-080)
A3: Third resubmission (not permitted)

Become to Resubmission (Amended) Applications

Too Many Resubmissions Have Been Received

Source: https://grants.nih.gov/grants/policy/resubmission_q&a.htm

Share this post